Translational research in oncology—10 years of progress and future prospects
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Translational research in oncology—10 years of progress and future prospects
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 11, Issue 11, Pages 649-662
Publisher
Springer Nature
Online
2014-10-07
DOI
10.1038/nrclinonc.2014.158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Validation of a hypoxia-inducible factor-1 alpha specimen collection procedure and quantitative enzyme-linked immunosorbent assay in solid tumor tissues
- (2014) Sook Ryun Park et al. ANALYTICAL BIOCHEMISTRY
- National Cancer Institute Biospecimen Evidence-Based Practices: A Novel Approach to Pre-analytical Standardization
- (2014) Kelly B. Engel et al. BIOPRESERVATION AND BIOBANKING
- Antibody-modified T cells: CARs take the front seat for hematologic malignancies
- (2014) M. V. Maus et al. BLOOD
- Long-term impact of the 70-gene signature on breast cancer outcome
- (2014) C. A. Drukker et al. BREAST CANCER RESEARCH AND TREATMENT
- From Cancer Genomics to Precision Oncology—Tissue’s Still an Issue
- (2014) Robert L. Cohen et al. CELL
- Implementation of Validated Pharmacodynamic Assays in Multiple Laboratories: Challenges, Successes, and Limitations
- (2014) R. Kinders et al. CLINICAL CANCER RESEARCH
- Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer
- (2014) D. R. Parkinson et al. CLINICAL CANCER RESEARCH
- Pharmacodynamic Biomarkers: Falling Short of the Mark?
- (2014) J. F. Gainor et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer
- (2014) A. Mishra et al. CLINICAL CANCER RESEARCH
- 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
- (2014) S. B. M. Gaykema et al. CLINICAL CANCER RESEARCH
- Organoid cultures for the analysis of cancer phenotypes
- (2014) Norman Sachs et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Immune Checkpoint Blockade
- (2014) Jarushka Naidoo et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Prostate cancer vaccines in combination with additional treatment modalities
- (2014) Matthew A. Uhlman et al. IMMUNOLOGIC RESEARCH
- Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report
- (2014) Rehan Akbani et al. MOLECULAR & CELLULAR PROTEOMICS
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Molecular analysis of circulating tumour cells—biology and biomarkers
- (2014) Matthew G. Krebs et al. Nature Reviews Clinical Oncology
- Development of a PET radiotracer for non-invasive imaging of the reactive oxygen species, superoxide, in vivo
- (2014) Wenhua Chu et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
- (2014) E. Tran et al. SCIENCE
- Molecular Analysis for Therapy Choice: NCI MATCH
- (2014) Barbara A. Conley et al. SEMINARS IN ONCOLOGY
- Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
- (2014) D. A. Haber et al. Cancer Discovery
- Radiation Induces Diffusible Feeder Cell Factor(s) That Cooperate with ROCK Inhibitor to Conditionally Reprogram and Immortalize Epithelial Cells
- (2013) Nancy Palechor-Ceron et al. AMERICAN JOURNAL OF PATHOLOGY
- A Call to Standardize Preanalytic Data Elements for Biospecimens
- (2013) James A. Robb et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration
- (2013) Lisa M McShane et al. BMC Medicine
- Molecular mechanisms underlying chronic inflammation-associated cancers
- (2013) Yongzhong Wu et al. CANCER LETTERS
- Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models
- (2013) D. Siolas et al. CANCER RESEARCH
- The Exomes of the NCI-60 Panel: A Genomic Resource for Cancer Biology and Systems Pharmacology
- (2013) O. D. Abaan et al. CANCER RESEARCH
- GWAS Meets TCGA to Illuminate Mechanisms of Cancer Predisposition
- (2013) Hyun Seok Kim et al. CELL
- Influence of Metabolism on Epigenetics and Disease
- (2013) William G. Kaelin et al. CELL
- Interplay between the Cancer Genome and Epigenome
- (2013) Hui Shen et al. CELL
- Lessons from the Cancer Genome
- (2013) Levi A. Garraway et al. CELL
- United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies
- (2013) Woondong Jeong et al. CURRENT PROBLEMS IN CANCER
- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- CAR T cells: driving the road from the laboratory to the clinic
- (2013) Eleanor J. Cheadle et al. IMMUNOLOGICAL REVIEWS
- Design and development of therapies using chimeric antigen receptor-expressing T cells
- (2013) Gianpietro Dotti et al. IMMUNOLOGICAL REVIEWS
- Exploiting tumor metabolism: challenges for clinical translation
- (2013) Matthew G. Vander Heiden JOURNAL OF CLINICAL INVESTIGATION
- From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development
- (2013) C. H. Lieu et al. JNCI-Journal of the National Cancer Institute
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Safety and feasibility of targeted agent combinations in solid tumours
- (2013) Sook Ryun Park et al. Nature Reviews Clinical Oncology
- Appraising iniparib, the PARP inhibitor that never was—what must we learn?
- (2013) Joaquin Mateo et al. Nature Reviews Clinical Oncology
- Metabolic targets for cancer therapy
- (2013) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Overcoming Resistance to Targeted Anticancer Drugs
- (2013) James H. Doroshow NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas
- (2013) Sibaprasad Bhattacharyya et al. NUCLEAR MEDICINE AND BIOLOGY
- Ipilimumab and Its Toxicities: A Multidisciplinary Approach
- (2013) L. A. Fecher et al. ONCOLOGIST
- Imaging CXCL12-CXCR4 Signaling in Ovarian Cancer Therapy
- (2013) Emma Salomonnson et al. PLoS One
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Growing Self-Organizing Mini-Guts from a Single Intestinal Stem Cell: Mechanism and Applications
- (2013) T. Sato et al. SCIENCE
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
- (2013) D. Rohle et al. SCIENCE
- Targeted Inhibition of Mutant IDH2 in Leukemia Cells Induces Cellular Differentiation
- (2013) F. Wang et al. SCIENCE
- Molecularly targeted cancer therapy: some lessons from the past decade
- (2013) Min Huang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Role of Aspirin in Cancer Prevention
- (2013) Mangesh A. Thorat et al. Current Oncology Reports
- Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
- (2013) Shunqiang Li et al. Cell Reports
- Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
- (2012) Giorgio Trinchieri Annual Review of Immunology
- Mechanisms of resistance to BCR-ABL and other kinase inhibitors
- (2012) Allan Joaquim Lamontanara et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
- (2012) Carolina Navas et al. CANCER CELL
- Abstract 3620: A multiplex quantitative immunofluorescence assay for DNA damage repair in response to cytotoxic treatment
- (2012) Allison M. Marrero et al. CANCER RESEARCH
- Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes
- (2012) M. Singh et al. CANCER RESEARCH
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
- (2012) S. Kopetz et al. CLINICAL CANCER RESEARCH
- 27 NCI-60 Combination Screening Matrix of Approved Anticancer Drugs
- (2012) S. Holbeck et al. EUROPEAN JOURNAL OF CANCER
- What We Have Learned About Pancreatic Cancer From Mouse Models
- (2012) Pedro A. Pérez–Mancera et al. GASTROENTEROLOGY
- Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
- (2012) Paolo A Ascierto et al. Journal of Translational Medicine
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- Cancer biomarkers: selecting the right drug for the right patient
- (2012) Gary J. Kelloff et al. NATURE REVIEWS DRUG DISCOVERY
- Understanding and learning from the success of prophylactic human papillomavirus vaccines
- (2012) John T. Schiller et al. NATURE REVIEWS MICROBIOLOGY
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review of functional/anatomical imaging in oncology
- (2012) Stephanie N. Histed et al. NUCLEAR MEDICINE COMMUNICATIONS
- Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells
- (2012) F. A. Suprynowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome Sequencing Identifies a Basis for Everolimus Sensitivity
- (2012) G. Iyer et al. SCIENCE
- Intratumor Heterogeneity: Seeing the Wood for the Trees
- (2012) T. A. Yap et al. Science Translational Medicine
- Inflammation and colorectal cancer: colitis-associated neoplasia
- (2012) Sergei I. Grivennikov Seminars in Immunopathology
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced Senescence
- (2011) Carmen Guerra et al. CANCER CELL
- Phase I Study of PARP Inhibitor ABT-888 in Combination with Topotecan in Adults with Refractory Solid Tumors and Lymphomas
- (2011) S. Kummar et al. CANCER RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Synthetic lethality of PARP inhibition in cancers lackingBRCA1andBRCA2mutations
- (2011) Konstantin J. Dedes et al. CELL CYCLE
- Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
- (2011) F. Molinari et al. CLINICAL CANCER RESEARCH
- Current status of genome-wide association studies in cancer
- (2011) Charles C. Chung et al. HUMAN GENETICS
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
- (2011) S. Roychowdhury et al. Science Translational Medicine
- Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
- (2011) L. V. Sequist et al. Science Translational Medicine
- The BATTLE Trial: Personalizing Therapy for Lung Cancer
- (2011) Edward S. Kim et al. Cancer Discovery
- Monitoring Drug-Induced H2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells
- (2010) L. H. Wang et al. CLINICAL CANCER RESEARCH
- Development of a Validated Immunofluorescence Assay for H2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity
- (2010) R. J. Kinders et al. CLINICAL CANCER RESEARCH
- Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
- (2010) Dora Dias-Santagata et al. EMBO Molecular Medicine
- International network of cancer genome projects
- (2010) Thomas J. Hudson (Chairperson) et al. NATURE
- Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements
- (2010) Shivanni Kummar et al. NATURE REVIEWS DRUG DISCOVERY
- Prognostic Implications of HPV in Oropharyngeal Cancer
- (2010) Douglas R. Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Tumor suppressors and cell metabolism: a recipe for cancer growth
- (2009) R. G. Jones et al. GENES & DEVELOPMENT
- Perspectives on the development of imatinib and the future of cancer research
- (2009) Brian J Druker NATURE MEDICINE
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Oncologic Phase 0 Trials Incorporating Clinical Pharmacodynamics: from Concept to Patient
- (2008) J. H. Doroshow et al. CLINICAL CANCER RESEARCH
- Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts
- (2008) R. J. Kinders et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now